Class IITerminatedD-0224-2019
Drug recall · November 14, 2018
BEVACIZUMAB 2.5 MG/0.1ML recall
Why: Lack of Assurance of Sterility
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
BEVACIZUMAB 2.5 MG/0.1ML, pre-filled syringe (deliverable dose of 1.25MG in normject syringe) Repackaged by Avella Specialty Pharmacy, 24416 N 19th Avenue, Pheonix, AZ 85085. NDC 42852-001-24
- Lots / codes
Lot # 138-20182408@58 BUD 12/22/2018
- Quantity
- 911 syringes
- Company
- Avella of Deer Valley, Inc. Store 38, Phoenix, AZ
- Distribution
- Product was distributed throughout the United States.
- Initiated
- October 31, 2018 · Voluntary: Firm initiated
- Classified
- November 7, 2018
- Reported
- November 14, 2018
- Ended
- January 18, 2019
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.